ArticleFrontiers in ophthalmology2026
Global challenges for lens and cataract research.
Article in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The lens is sadly too often dismissed as a less important tissue within the eye, but this neglects to appreciate the role it plays in the wellbeing and quality of life of individuals, the economic burden lens pathologies place on society and the true biological wonder it is! A normal healthy lens in isolation, looks like a jewel, formed from biological glass. The lens is made of cells enveloped in a soft collagen shell. No blood supply, no nerves. There is slow cell growth that occurs progressively over a lifetime and little cell death takes place. Furthermore, the lens is not a static system and has to quite literally accommodate and manage ongoing mechanical changes due to shape-changing accommodation. Despite these challenges, lens cells are orchestrated to perfect harmony to generate an anatomy conducive to transparency, refraction and accommodation. Pathologies of the lens compromise wellbeing. Congenital and early onset cataract can lead to blindness in tens of thousands of people, while in later life age-related cataracts lead to visual deterioration and blindness in tens of millions. The only treatment for cataract is surgery with intraocular lens (IOL) implantation. Cataract surgery is the most common operation in the world and IOLs the most common medical implant. Despite the success of cataract surgery, wound-healing responses lead to secondary visual loss, known as posterior capsule opacification, in approximately 20% of patients. This can be resolved by Nd: YAG Capsulotomy, but this is not without risk; this is the second most common operation in the world. In addition, presbyopia commonly present in middle age and affects billions, impacting personal wellbeing and ability to perform specific roles. Collectively, these conditions compromise individuals and place significant financial burdens on healthcare providers. The need to undertake lens and cataract research therefore remains a key health priority. As a community the lens field faces both medical and political challenges that need to be considered, appreciated and addressed. In the current article the lens and cataract research landscape is assessed and evaluated with potential strategies proposed to build on existing strengths and address areas of underused potential to continue advancing knowledge and impact on the health and wellbeing of millions and potentially billions of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.